Digoxin’s Second Chance Just Ran Out: What a Failed Phase 3 RCT Reveals About Cardiovascular Drug Development
Low-dose digoxin cut hospitalizations but missed its primary endpoint in a 1,400-patient RCT—exposing a gap between statistical significance and...